Nancy Stagliano Founder of Neuron23 Backed byKleiner PerkinsRedmile GroupSoftBank Vision FundJeremy GreenMasayoshi SonNadia Cochinwala LinkedIn SourcesNeuron23 Announces $96.5 Million Series D Financing and First Patient Dosed in Global Phase 2 NEULARK Clinical Trial of NEU-411 for Early Parkinson’s Disease — 2025-06 Browse all founders · Browse investors
